04 January 2018: Articles
An Autopsy Case of Mesenteric Panniculitis with Massive Pleural Effusions
Challenging differential diagnosis, Rare disease
Hiroshi Kobayashi ABCDEFG 1*, Kenji Notohara CDF 2, Tadashi Otsuka ABC 3, Yuka Kobayashi BCF 4, Masuo Ujita BD 5, Yuuki Yoshioka B 3, Naomasa Suzuki B 6, Ryuji Aoyagi AB 3, Riuko Ohashi DF 7, Toshimitsu Suzuki EF 1DOI: 10.12659/AJCR.905744
Am J Case Rep 2018; 19:13-20
Abstract
BACKGROUND: Mesenteric panniculitis (MP) is an idiopathic chronic inflammatory condition of the mesentery. The main symptoms include abdominal pain, abdominal distention, weight loss, fever, nausea, and vomiting. The patients also present with chylous ascites in 14% of the cases and chylous pleural effusion (CPE) in very rare occasions. Despite the previous view of excellent prognosis of MP, two recent papers reported several fatal cases. However, there are still only a few autopsy case reports that describe the macroscopic and histological details of MP cases.
CASE REPORT: The patient was an 81-year-old Japanese woman. She complained of edema of her lower legs and face, general fatigue, and dyspnea. She was overweight and had type 2 diabetes (T2D). Computerized tomography (CT) demonstrated massive bilateral pleural effusions, with mild pericardial effusion and mild ascites. There was no pulmonary, cardiac or hepatic condition to explain the effusions. However, MP was suspected based on her CT. She gradually deteriorated into respiratory failure. The autopsy revealed CPEs (left 1,300 mL, right 1,400 mL) and MP in the mesentery of the small intestine. Neither neoplasia nor inflammatory conditions other than MP were detected.
CONCLUSIONS: In rare occasions, patients with MP present with CPE or chylothorax. We thought that a possible mechanism of the CPEs was a diaphragmatic defect. We suspected that being overweight and T2D had an etiological relationship with MP in our patient’s case. Adipose tissue of the mesentery is the main focus of MP. We believed that MP would be the best umbrella term of the many synonyms.
Keywords: Mesentery, Panniculitis, Pleural Effusion
Background
Mesenteric panniculitis (MP) is a rare or underdiagnosed inflammatory condition of unknown etiology in the adipose tissue of the mesentery [1–3]. MP or sclerosing mesenteritis is most often used as the umbrella term for many synonyms [4–10].
The main symptoms include abdominal pain (68–78%), nausea and vomiting (6–32%), abdominal distention (9–26%), fever (6–26%), diarrhea (7–25%), and constipation (6–15%) [3,11,12]. Some of the case reports on MP patients have reported no associated symptoms [5,11,12]. In rare occasions, a patient may present with ascites, usually of the chylous type [1,11]. The report of MP with massive ascites is rare [13–18]. The report of MP with massive chylous pleural effusion (CPE) or chylothorax is extremely rare [19,20].
Physical examination, when positive, may reveal abdominal tenderness (24–38%) and mass (15–34%) [3,11,12]. Elevation of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) is frequently observed, with other abnormalities infrequent on blood tests [11,12]. More than half of the cases of MP were suggestive of the disease on computerized tomography (CT) [11], but a histological diagnosis was required in most of the cases [12].
Following diagnosis of MP, the chief management strategies for the patient are “watchful waiting”, medical treatment, and surgical resection [12]. Complications of the disease include bowel obstruction and perforation, ischemia, ileus, peritonitis, sepsis, and therapy-related complications [11,12].
Generally, MP is considered to have an excellent prognosis [3,4]. However, a recent systemic review and the largest case series have reported some cases that had poor prognosis [11,12]. The mortality rate due to complications of MP was reported to be 6.3% [12]. There are only a few autopsy case reports of MP available in the English literature, mainly because the absolute number of fatal cases is very small [1,21–23].
Case Report
AUTOPSY FINDINGS:
Autopsy was performed to confirm the CT diagnosis and to elucidate the pathophysiology of the effusions.
Bilateral, white-yellow, turbid pleural effusions (left 1,300 mL, right 1,400 mL) were found on autopsy. However, pleuritis, pneumonia, and congestive edema were not demonstrated. Both lungs had the same weight of 200 g. There were no detected bilateral diaphragmatic defects. Pericardial effusion of 150 mL, and mild and chronic pericarditis were found. The heart weight was 350 g. Mild hypertrophy of the left ventricle with a wall thickness of 1.5 cm and moderate coronary sclerosis was revealed. No dilatation of the ventricles and no mural thrombosis were found. A calcified nodule 2.2×0.8 cm in size was observed at the mitral annulus. Histology of the heart did not show infarcts or cardiomyopathy.
Ascites of 200 mL was observed and peritonitis was not found. Diffuse thickening of the small bowel mesentery was demonstrated (Figure 2A). The size of the lesion was approximately 12×11×2.5 cm. There was focal and mild thickening of the peritoneum in the mesentery. No adhesion between the small bowel and the mesentery was found. The cut sections showed that patchy white-yellow areas intermingled with brown-yellow areas surrounding the mildly swollen mesenteric lymph nodes (Figure 2B). Histology of the white-yellow area revealed aggregates of foamy macrophages and moderate fibrosis of no specific pattern, as in storiform fibrosis (Figure 3A, 3B). Histology of the brown-yellow area demonstrated mild-to-moderate panniculitis, with mild-to-moderate infiltration of small lymphocytes and plasma cells, mild-to-moderate degeneration of adipocytes, and mild fibrosis (Figure 3C, 3D). Immunohistochemically, the small lymphocytes consisted of B and T lymphocytes. And IgG4 positive plasma cells focally increased. Neither necrotizing arteritis nor occlusive phlebitis was found. The mesenteric lymph nodes revealed mild reactive hyperplasia with no findings of malignant lymphoma and metastatic tumors.
The liver was atrophic and the weight was 620 g. Nevertheless, there were no findings of hepatitis, fibrosis, or cholestasis. The small and large bowels did not reveal any macroscopic or microscopic abnormalities. The pancreas showed moderate fatty infiltration and the weight was 140 g. Focal panniculitis-like inflammation in the peri-pancreatic adipose tissue were observed.
The weight of the left and the right kidney was 150 g and 120 g, respectively. The finely granular surfaces suggested moderate arteriosclerotic atrophy. The cut sections showed mild atrophy and mild dilatation of the pelvis. The histology demonstrated moderate glomerular sclerosis and hyalinosis of the arterioles, which was consistent with diabetic renal changes. Neither tubulointerstitial nephritis nor retroperitoneal fibrosis was found.
Discussion
MP is a chronic inflammatory process mainly involving fatty tissue of the mesentery. A previous report showed that around 40% of cases had no symptoms [5]. But two recent reports indicated that patients with MP, which was incidentally identified, were 10% of 92 cases and 1.6% of 192 cases, respectively [11,12]. MP is usually diagnosed during the fifth or sixth decade of life and it is twice as common in men as in women. Its main symptoms include abdominal pain, abdominal distention, weight loss, fever, nausea, and vomiting [3,11,12]. The laboratory tests often show elevation of CRP and ESR with infrequency of leukocytosis, anemia, and low level of total serum protein [12]. In more than half of the patients, CT findings were suggestive of MP, but in at least one fourth of cases, the radiologic or gross appearance was indistinguishable from a malignant process, especially lymphoma [11]. In one study, although CT scan was performed in the majority of patients, only 15.1% (n=26) were diagnosed based on the imaging studies; thus, histology remained the gold standard despite invasive testing [12].
Despite previous reports of excellent prognosis of MP [3,4], a systemic review reported that there was a total of 14 deaths (7.3% of 192 cases), 12 of which was secondary to MP-related complications [12]. The largest series reported poor prognosis in 20% of the cases and three deaths attributed to complications of the condition or its treatment [11]. On the other hand, there have been very few autopsy reports from the fatal cases probably due to the scarcity of such cases [1,21–23]. MP was found as an incidental finding at autopsy in one report [11].
The main symptom of our patient was dyspnea, which was caused by massive CPEs. The CT scan suggested MP in the small bowel mesentery. At autopsy, we identified MP in the mesentery. However, there were no specific lesions in any other organs which were likely to lead to the patient’s effusions.
Regarding ascites in MP, two English papers reported chylous ascites, the frequency of which was 14% (13/92) and 18.5% (5/27), respectively [1,11]. Although the amount was usually small [1], massive chylous ascites was reported in several cases, most of which were Japanese [13–18]. Mechanism of the chylous ascites was believed to be direct mechanical compression by the mesenteric mass encasing the bowel, blood vessels, and lymphatics that resulted in abdominal pain, bowel obstruction, ischemia, and chylous ascites [11]. Therefore, production of the ascites may be differently influenced by three types of mesenteric lesions: a single mass, multiple masses, and diffuse thickening [4,5]. MP is more frequent in the large bowel (64%) than in the small bowel mesentery (36%) in Japan [26]. And yet it is more common in the small bowel (69%) than in the large bowel mesentery (22.6%) in the Unites States [4]. The small bowel mesentery was involved in all the cases with massive chylous ascites [13–18]. Other types of ascites seem to be very rare without the complications, including bowel perforation, ischemic change, cardiogenic shock, and secondary infection [22,23,27–29].
Generally, CPE develops in a wide variety of conditions that bring about disruption of the large intrathoracic lymphatics due to traumatic injury or obstruction by benign or malignant causes [30]. It also presents itself in intra-abdominal conditions which include hepatitis, cirrhosis, primary sclerosing cholangitis, pancreatitis, malignancy of the bile duct or pancreas, and abdominal surgery [30]. To the best of our knowledge, there have been only two single-case reports of MP with massive CPE [19,20]. CPE was bilateral in one case and right in the other. As with our case, both of these cases had a small amount of ascites. It is hard to explain the exact mechanism of massive fluid accumulation almost exclusively in the pleural cavity in MP, mainly involving the mesenteric adipose tissue. However, it has been reported that massive hydrothorax happens through diaphragmatic defects in some cirrhotic patients (hepatic hydrothorax) [31,32] and in peritoneal dialytic patients with end-stage kidney diseases [33,34]. The negative intrathoracic pressure favors the transfer of fluid across the defect and hence patients usually have mild ascites [32]. The mechanism of the right CPE with MP was presumed to be a diaphragmatic defect [20], and hepatic hydrothorax is usually right-sided (65–87% of reported cases). However, it may be left-sided or bilateral [35]. As the defect can sometimes be microscopic in size [32], we could not identify it clinically and macroscopically at autopsy. Therefore, the mechanism in our case remains to be elucidated.
Etiology of MP is still unknown. A few reports have shown a high association of malignant neoplasia with MP, which has thus been considered a neoplastic syndrome [36–38]. Nevertheless, other articles have suggested that the prevalence of malignancy in MP was not higher than that in the general population [2,12]. We did not observe any neoplasia in our case at autopsy. Patients with MP have been reported to often have a past history of abdominal surgery or trauma [11,12]. Our patient had a history of appendectomy in her childhood. In a recent review, the theory of abnormal post-surgical healing and ischemia to the mesentery, as a source of MP, seemed plausible [12]. However, Emory et al. showed that only four of 84 cases with MP had a history of trauma and surgery [4]. A matched case-control study observed no significant difference in the rate of previous surgery between the two groups [2]. A small number of previous cases with MP shared some features with IgG4-related disease (IgG4-RD), including increase of IgG4-positive plasma cells and multifocal fibrosis [11,39–41]. Histology of our case revealed focal and moderate increase of IgG4-positive plasma cells and did not show occlusive phlebitis or storiform fibrosis. These findings and the absence of multifocal fibrosis were inconsistent with those of IgG4-RD. A recent paper suggested that most cases of MP are more likely to be an IgG4-RD mimic and that IgG4-RD seemingly seldom, if ever, affects this anatomic site [42].
Our patient was overweight and had T2D. Her BMI was recalculated to be 27.9 by subtracting the weight of the effusions from the body weight. In the available articles, only a few reports have put a focus of their studies on the relationship between MP and T2D or obesity. Pereira et al. reported that five cases of T2D were found on CT to have MP [43]. They hypothesized that changes in the mesenteric adipose tissue in inflammatory states (MP) might be similar to T2D because inflammation has been recognized to play a role in pathophysiology of T2D. Unlu et al. noted that people with idiopathic misty mesentery had high BMIs: 67.5% were classified as obese and 17.5% as overweight [44]. Misty mesentery is also considered to be an important CT sign indicating early stage of MP. And they suggested that there might be an association between obesity and misty mesenteric appearance on CT. According to comprehensive reviews, obesity and T2D are associated with low-grade chronic inflammatory processes [45–48]. In addition, human mesenteric adipose tissue is considered as a critical player in insulin resistance of T2D and metabolic syndrome [49]. These evidences may reinforce a close relationship between MP and obesity as well as T2D. However, a matched case-control study failed to demonstrate a significant association between MP and T2D [2]. Further study is needed to establish the association.
Fundamental histology of the mesentery consists of the surface mesothelium, connective lattice, and adipocyte population housed in interstices of the lattice [50]. Based on the definition of the mesentery, the term mesenteritis should properly mean that it is an inflammatory process involving the peritoneum, connective tissue including fibrous tissue, vessels, nerves, and adipose tissue. However, according to four case series studies and two reviews, ascites was not described as a major sign except for the small percentage of cases with chylous ascites [1,3–5,11,12]. Ogden et al. reported that they found no instances of adhesions binding of peritoneum-to-peritoneum or peritoneum-to-bowel or to other viscera; the peritoneum may hardly ever be involved in the condition. Phlebitis seldom if ever happens in ordinary cases of MP, but may in those with suspected IgG4-RD [42]. An emerging concept of the possible relationship between MP and obesity and/or T2D suggests that MP may be an inflammation exclusively involving the mesenteric adipose tissue [43,44]. Hence, we believe that mesenteric panniculitis would be the best umbrella term to encompass a spectrum of rare idiopathic diseases characterized by chronic and fibrotic inflammatory changes in adipose tissue of the mesentery.
Conclusions
We reported a rare autopsy case of MP with massive CPEs. We thought a possible mechanism of the fluid accumulation was a diaphragmatic defect. But it remains to be clarified. We could not identify any certain etiology for MP in our patient. It has recently been suggested that obesity and T2D have an association with MP. We suspected our patient’s overweight condition and/or T2D as the potential etiology.
The adipose tissue of the mesentery is the main focus of MP. And the other components of the mesentery are rarely involved in MP. We thought that MP would be the best umbrella term for the synonyms in this case report.
References:
1.. Ogden WW, Bradburn DM, Rives JD, Mesenteric panniculitis: Review of 27 cases: Ann Surg, 1965; 161; 864-73, pmid: 14295938
2.. Gögenbakan Ö, Albrecht T, Osterhoff MA, Is mesenteric panniculitis truly a paraneoplastic phenomenon? A matched pair analysis: Eur J Radiol, 2013; 82; 1853-59, pmid: 23906444
3.. Durst AL, Freund H, Rosenmann E, Mesenteric panniculitis: Review of the literature and presentation of cases: Surgery, 1977; 81; 203-11, pmid: 835091
4.. Emory TS, Monihan JM, Carr NJ, Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: A single entity?: Am J Surg Pathol, 1997; 21; 392-98, pmid: 9130985
5.. Kipfer RE, Moertel CG, Dahlin DC, Mesenteric lipodystrophy: Ann Intern Med, 1974; 80; 582-88, pmid: 4499963
6.. Jura V, [Sulla mesenterite retrattile e sclerosante.]: Policlinico (sez. Chir), 1924; 31; 575-81 [in Italian]
7.. Herrington JL, Edwards WH, Grossman LA, Mesenteric manifestations of Weber-Christian disease: Ann Surg, 1961; 154; 949-55, pmid: 13906825
8.. Yannopoulos K, Stout AP, Primary solid tumors of the mesentery: Cancer, 1963; 16; 914-27, pmid: 14043764
9.. DeCastro J, Calem WS, Papadakis L, Liposclerotic mesenteritis: Arch Surg, 1967; 94; 26-29, pmid: 6017460
10.. Wu LP, Yunis EJ, Fetterman WF, Inflammatory pseudo-tumors of the abdomen: plasma cell granulomas: J Clin Path, 1973; 26; 943-48, pmid: 4784503
11.. Akram S, Pardi DS, Schaffner JA, Sclerosing mesenteritis: Clinical features, treatment, and outcome in ninety-two patients: Clin Gastroenterol Hepatol, 2007; 5; 589-96, pmid: 17478346
12.. Sharma P, Yadav S, Needham CM, Sclerosing mesenteritis: A systemic review of 192 cases: Clin J Gastroenterol, 2017; 10(2); 103-11, pmid: 28197781
13.. Mizutani K, Konishi J, Hayashida R, [A case of mesenteric panniculitis associated with large amounts of chylous ascites]: J Jpn Surg Assoc, 2003; 64; 902-6 [in Japanese]
14.. Yoshimoto Y, Shimizu R, Saeki T, [A case of recurrent mesenteric panniculitis with large amounts of chylous ascites]: Jpn J Gastroenterol Surg, 2004; 37; 697-701 [in Japanese]
15.. Nishiya D, Mikami T, Fukuda S, [A case of suspected mesenteric panniculitis with a large amount of chylous ascites]: J Jpn Soc Gastroenterol, 2007; 104; 1212-17 [in Japanese]
16.. Arora M, Dubin E, A clinical study: Sclerosing mesenteritis presenting as chylous ascites: Medscape J Med, 2008; 10; 30-33, pmid: 18382700
17.. Kubo S, Idani H, Asami S, [A case of mesenteric panniculitis with massive chylous ascites]: J Jpn Surg Assoc, 2011; 72; 801-5 [in Japanese]
18.. Watanabe M, Noda S, Nishimura S, [A case of mesenteric panniculitis with massive chylous ascites]: J Jpn Surg Assoc, 2013; 74; 2787-91 [in Japanese]
19.. Fujino S, Kohno N, Inoue Y, [A case of chylous thorax caused by mesenteric panniculitis]: Jpn J Geriat, 1995; 32; 516-19 [in Japanese]
20.. Rice BL, Stoller JK, Heresi GA, Transudative chylothorax associated with sclerosing mesenteritis: Respir Care, 2010; 55; 475-77, pmid: 20406516
21.. Soergel KH, Hensley GT, Fetal mesenteric panniculitis: Gastroenterology, 1966; 51; 529-36, pmid: 5922950
22.. Andersen JA, Rasmussen NR, Pedersen JK, Mesenteric panniculitis: A fetal case: Am J Gastroenterol, 1982; 707; 523-25
23.. Kida T, Suzuki K, Matsuyama T, Sclerosing mesenteritis presenting as protein-losing enteropathy: A fetal case: Intern Med, 2011; 50; 2845-49, pmid: 22082901
24.. Light RW, MacGregor MI, Luchsinger PC, Pleural effusions: The diagnostic separation of transudates and exudates: Ann Intern Med, 1972; 77; 507-13, pmid: 4642731
25.. Staats BA, Ellefson RD, Budahn L, The lipoprotein profile of chylous and nonchylous pleural effusions: Mayo Clin Proc, 1980; 55; 700-4, pmid: 7442324
26.. Iwata G, Muto F, Kurioka H, [Mesenteric panniculitis-report of two cases]: J Jpn Surg Assoc, 1999; 60; 1921-25 [in Japanese]
27.. Katsanos KH, Ioachim E, Michail M, A fetal case of sclerosing mesenteritis: Dig Liver Dis, 2004; 36; 153-56, pmid: 15002825
28.. Chawla S, Yalamarthi S, Shaikh IA, An unusual presentation of sclerosing mesenteritis as pneumoperitoneum: Case report with a review of the literature: World J Gastroenterol, 2009; 15; 117-20, pmid: 19115477
29.. Daumas A, Agostini S, Villeret J, Spontaneous resolution of severe, symptomatic mesocolic panniculitis: A case report: BMC Gastroenterol, 2012; 12; 59-63, pmid: 22672224
30.. Skouras V, Kalomenidis I, Chylothorax: Diagnostic approach: Curr Opin Pulm Med, 2010; 16; 387-93, pmid: 20410823
31.. Strauss RM, Boyer TD, Hepatic hydrothorax: Semin Liver Dis, 1997; 17; 227-32, pmid: 9308127
32.. Cardenas A, Keller T, Chopra S, Review article: hepatic hydrothorax: Aliment Pharmacol Ther, 2004; 20; 271-79, pmid: 15274663
33.. Fernando SK, Salzano R, Reynolds JT, Peritoneal dialysis – related hydrothorax – case report: Adv Perit Dial, 2006; 22; 158-61, pmid: 16983961
34.. Argento AC, Kim A, Knauert-Brown M, Recurrent hydrothorax and surgical diaphragmatic repair. Report of 2 cases and review of the literature: Bronchol Intervent Pulmol, 2014; 21; 150-53
35.. Roussos A, Philippou N, Mantzaris GJ, Hepatic hydrothorax: Pathophysiology diagnosis and management: J Gastroenterol Hapatol, 2007; 22; 1388-93
36.. Putte-Katier NV, Bommel EFHV, Elgersma OE, Mesenteric panniculitis: Prevalence, clinicoradiological presentation and 5-year follow-up: Br J Radiol, 2014; 87; 20140451, pmid: 25271412
37.. Daskalogiannaki M, Voloudaki A, Prassopoulos P, CT evaluation of mesenteric panniculitis: Prevalence and associated diseases: Am J Roentgenol, 2000; 174(2); 427-31, pmid: 10658720
38.. Badet N, Sailley N, Briquez C, Mesenteric panniculitis: Still an ambiguous condition: Diag Intern Imaging, 2015; 96; 251-57
39.. Binder SC, Deterling RA, Mahonny SA, Systemic idiopathic fibrosis. Report of a case of the concomitant occurrence of retractile mesenteritis and retroperitoneal fibrosis: Am J Surg, 1972; 124; 422-30, pmid: 5056907
40.. Medina-Franco H, Listinsky C, Wilcox CM, Concomitant sclerosing mesenteritis and bile duct fibrosis simulating Klatskin’s tumor: J Gastrointest Surg, 2001; 5; 658-60, pmid: 12086905
41.. Phillips RH, Carr RA, Preston R, Sclerosing mesenteritis involving the pancreas: Two cases of a rare cause of abdominal mass mimicking malignancy: Eur J Gastroenterol Hapatol, 1999; 11; 1323-29
42.. Avincsal MO, Otani K, Kanzawa M, Sclerosing mesenteritis: A rare manifestation or histological mimic of IgG4-related disease?: Pathol Int, 2016; 66; 158-63, pmid: 26811214
43.. Pereira JPT, Romão V, Eulálio M, Sclerosing mesenteritis and disturbance of glucose metabolism: A new relationship? A case series: Am J Case Rep, 2016; 17; 55-59, pmid: 26848804
44.. Unlu E, Okur N, Acay MB, The prevalence of incidentally detected idiopathic misty mesentery on multidetector computed tomography: Can obesity be the triggering cause?: Can Assoc Radio J, 2016; 67; 212-17
45.. Li J, Li F, Zao A, Inflammation and leptin: Drug Discov Today, 2006; 3; 387-93
46.. Donath MY, Shoelson S, Type 2 diabetes as an inflammatory disease: Nat Rev Immunol, 2011; 11; 98-107, pmid: 21233852
47.. Chawla A, Nguyen K, Goh YPS, Macrophage-mediated inflammation in metabolic disease: Nat Rev Immunol, 2012; 11; 738-49
48.. Guilherme A, Virbasius JV, Puri V, Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes: Nat Rev Mol Cell Biol, 2008; 9; 365-77
49.. Yang Y-K, Chen M, Clements RH, Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes: Cell Physiol Biochem, 2008; 22; 531-38, pmid: 19088435
50.. Coffey JC, O’leary DP, The mesentery: Structure, function, and role in disease: Lancet Gastroenterol Hepatol, 2016; 1; 238-47, pmid: 28404096
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






